Araştırma Makalesi

Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis?

Cilt: 6 Sayı: 4 1 Aralık 2021
PDF İndir
TR EN

Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis?

Öz

Objective: Neutrophil-lymphocyte ratio (NLR) and monocyte-lymphocyte ratio (MLR) are useful biomarkers of inflammation used to evaluate bacteremia, disease activity, recurrence rate, surveillance and prognosis in many diseases. In this study, we evaluated NLR and MLR of 92 children with tuberculosis versus 45 healthy children to show whether they can be used as inflammation markers. Aim of this study was to evaluate the diagnostic valure of NLR and MLR in childhood tuberculosis.
Materials and Methods: In this retrospective study, hospital records of 92 children with tuberculosis were reviewed. The NLR and MLR values of the patients were compared with the control group of 45 healthy children.
Results: A significant difference was found between NLO and MLO values between tuberculosis and control groups (p <0.001). A cut off value of NLR>1.41was optimal for discriminating patients with tuberculosis from controls (sensitivity 75%, specifity 82.2%, positive predictive value 89.6%, negative predictive value 61.7%). A cut off value of MLR>0.22 was optimal for discriminating patients with tuberculosis from controls (sensitivity 50%, specifity 91.1%, positive predictive value 93.3%, negative predictive value 53.2%).
Conclusions: NLR and MLR can both be used as inflammation biomarkers in the diagnosis of childhood tuberculosis. Prospective and more comprehensive studies are needed to make a clearer decision. 

Anahtar Kelimeler

Kaynakça

  1. World Health Organization. Global Tuberculosis Report 2018. https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?sequence=1&isAllowed=y. Accessed 12 November 2018.
  2. Burki T. Neglecting childhood tuberculosis "a human rights violation". Lancet Infect Dis. 2018;18(7):723. doi:10.1016/S1473-3099(18)30365-7
  3. Demir F, Karadeniz C, Özdemir R, et al. Usefulness of Neutrophil to Lymphocyte Ratio in Prediction of Coronary Artery Lesions in Patients with Kawasaki Disease. Balkan Med J. 2015;32(4):371-376. doi:10.5152/balkanmedj.2015.151108
  4. Uygur F, Tanriverdi H, Aktop Z, et al. The neutrophil-to-lymphocyte ratio in patients with obstructive sleep apnoea syndrome and its relationship with cardiovascular disease. Heart Lung. 2016;45(2):121-125. doi:10.1016/j.hrtlng.2016.01.002
  5. Kucuk A, Erol MF, Senel S, et al. The role of neutrophil lymphocyte ratio to leverage the differential diagnosis of familial Mediterranean fever attack and acute appendicitis. Korean J Intern Med. 2016;31(2):386-391. doi:10.3904/kjim.2015.039
  6. Gokcen K, Dundar G, Gulbahar H, Gokce G, Gultekin EY. Can routine peripheral blood counts like neutrophil-to-lymphocyte ratio be beneficial in prediagnosis of testicular cancer and its stages? J Res Med Sci. 2018;23:64. doi:10.4103/jrms.JRMS_1009_16
  7. Bozdemir ŞE, Altıntop YA, Uytun S, Aslaner H, Torun YA. Diagnostic role of mean platelet volume and neutrophil to lymphocyte ratio in childhood brucellosis. Korean J Intern Med. 2017;32(6):1075-1081. doi:10.3904/kjim.2016.092
  8. Yoon NB, Son C, Um SJ. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann Lab Med. 2013;33(2):105-110. doi:10.3343/alm.2013.33.2.105

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

1 Aralık 2021

Gönderilme Tarihi

25 Mart 2021

Kabul Tarihi

2 Kasım 2021

Yayımlandığı Sayı

Yıl 2021 Cilt: 6 Sayı: 4

Kaynak Göster

APA
Elmas Bozdemir, Ş., & Aslaner, H. (2021). Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis? Online Turkish Journal of Health Sciences, 6(4), 521-527. https://doi.org/10.26453/otjhs.903130
AMA
1.Elmas Bozdemir Ş, Aslaner H. Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis? OTSBD. 2021;6(4):521-527. doi:10.26453/otjhs.903130
Chicago
Elmas Bozdemir, Şefika, ve Humeyra Aslaner. 2021. “Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis?”. Online Turkish Journal of Health Sciences 6 (4): 521-27. https://doi.org/10.26453/otjhs.903130.
EndNote
Elmas Bozdemir Ş, Aslaner H (01 Aralık 2021) Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis? Online Turkish Journal of Health Sciences 6 4 521–527.
IEEE
[1]Ş. Elmas Bozdemir ve H. Aslaner, “Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis?”, OTSBD, c. 6, sy 4, ss. 521–527, Ara. 2021, doi: 10.26453/otjhs.903130.
ISNAD
Elmas Bozdemir, Şefika - Aslaner, Humeyra. “Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis?”. Online Turkish Journal of Health Sciences 6/4 (01 Aralık 2021): 521-527. https://doi.org/10.26453/otjhs.903130.
JAMA
1.Elmas Bozdemir Ş, Aslaner H. Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis? OTSBD. 2021;6:521–527.
MLA
Elmas Bozdemir, Şefika, ve Humeyra Aslaner. “Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis?”. Online Turkish Journal of Health Sciences, c. 6, sy 4, Aralık 2021, ss. 521-7, doi:10.26453/otjhs.903130.
Vancouver
1.Şefika Elmas Bozdemir, Humeyra Aslaner. Can Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio Be Used in the Diagnosis of Childhood Tuberculosis? OTSBD. 01 Aralık 2021;6(4):521-7. doi:10.26453/otjhs.903130

Cited By

Creative Commons Lisansı
 

Online Türk Sağlık Bilimleri Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.

Bu, Creative Commons Atıf Lisansı (CC BY-NC 4.0) şartları altında dağıtılan açık erişimli bir dergidir. Orijinal yazar(lar) veya derginin adı ve bu dergideki orijinal yayının kabul görmüş akademik uygulamaya uygun olarak atıfta bulunulması koşuluyla, diğer forumlarda kullanılması, dağıtılması veya çoğaltılmasına izin verilir. Bu şartlara uymayan hiçbir kullanım, dağıtım veya çoğaltmaya izin verilmez.

Makale gönderme süreçleri ve "Telif Hakkı Devir Formu" hakkında yardım almak için tıklayınız.